Overview India’s healthcare ecosystem is expanding rapidly due to population growth, increasing lifestyle diseases, medical ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Palantir’s growth shifted from new contracts to expansion-led economics, supported by net dollar retention consistently above ...